What Researchers Did
The researchers measured nitric oxide (NO) related markers in the wound fluid and blood of 6 people with chronic wounds who responded well to hyperbaric oxygen therapy (HBOT).
What They Found
This preliminary study of 6 chronic wound patients who responded favorably to HBOT found that wound fluid nitrate and nitrite (NOx), the stable products of nitric oxide, were significantly elevated at 1 and 4 weeks after therapy. The treatment was 20 sessions at 2.0 ATA for 90 minutes. Wound fluid NOx tended to increase during treatments, and the levels correlated with reductions in wound area. Blood plasma L-arginine and asymmetric dimethylarginine (ADMA) did not change during or after HBOT. The abstract states that successful HBOT was associated with more granulation tissue and significantly improved wound closure.
What This Means for Canadian Patients
For people with chronic wounds, this small study looked only at patients who had already done well with HBOT. It suggests that higher nitric oxide levels in the wound may be one factor linked to healing, but it did not compare these patients with others. It does not show that HBOT caused the changes in nitric oxide or in wound healing.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The study was preliminary, included only 6 patients who had already responded favorably to HBOT, and had no comparison group, so it cannot show that HBOT caused the nitric oxide changes or the healing.